1. Home
  2. WMK vs STOK Comparison

WMK vs STOK Comparison

Compare WMK & STOK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Weis Markets Inc.

WMK

Weis Markets Inc.

N/A

Current Price

$75.67

Market Cap

1.8B

ML Signal

N/A

Logo Stoke Therapeutics Inc.

STOK

Stoke Therapeutics Inc.

N/A

Current Price

$26.17

Market Cap

2.0B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
WMK
STOK
Founded
1912
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Food Chains
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.8B
2.0B
IPO Year
1994
2019

Fundamental Metrics

Financial Performance
Metric
WMK
STOK
Price
$75.67
$26.17
Analyst Decision
Strong Buy
Analyst Count
0
14
Target Price
N/A
★ $46.46
AVG Volume (30 Days)
128.1K
★ 758.4K
Earning Date
11-06-2026
10-29-2026
Dividend Yield
★ 1.75%
N/A
EPS Growth
N/A
★ 92.73
EPS
★ 2.05
N/A
Revenue
★ $4,714,573,000.00
$184,420,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$39.98
P/E Ratio
$37.90
★ N/A
Revenue Growth
0.01
★ 404.50
52 Week Low
$59.99
$20.32
52 Week High
$83.74
$40.22

Technical Indicators

Market Signals
Indicator
WMK
STOK
Relative Strength Index (RSI) 53.71 51.08
Support Level $68.17 $24.21
Resistance Level $82.50 $33.61
Average True Range (ATR) 1.89 1.23
MACD 0.28 0.37
Stochastic Oscillator 43.31 76.79

Price Performance

Historical Comparison
WMK
STOK

About WMK Weis Markets Inc.

Weis Markets Inc is a U.S.-based company that is principally engaged in retailing food products in Pennsylvania and surrounding states. The company's products mainly belong to the following categories: center-store goods, fresh goods, pharmacy services, fuel, and others. The center-store goods include groceries, dairy products, frozen foods, alcoholic beverages, and general merchandise items. The fresh goods include meats, seafood, floral, prepared foods, and bakery products. The center-store goods and fresh goods jointly account for the majority of the company's total revenue.

About STOK Stoke Therapeutics Inc.

Stoke Therapeutics Inc is a biotechnology company dedicated to restoring protein expression by harnessing the body's potential with RNA medicine. Its proprietary TANGO (Targeted Augmentation of Nuclear Gene Output) approach, Stoke is developing antisense oligonucleotides (ASOs) to restore naturally-occurring protein levels selectively. Its first medicine in development, zorevunersen, has demonstrated the potential for disease modification in patients with Dravet syndrome. The company provides early programs focused on multiple targets, including haploinsufficiency diseases of the central nervous system and eye, to up-regulate the protein expression of the underlying disease gene in a mutation-agnostic manner.

Share on Social Networks: